Work

Analysis of human renal angiomyolipoma cells: pharmacological modulation of growth and migration in vitro

Type: dissertation
Abstract: Introduction: Renal angiomyolipomas (AMLs) are highly vascular masses variously composed by differentiated cells such as smooth muscle, adipose, and vascular endothelial cells.Pulmonary lymphangioleiomyomatosis (LAM) is an age and gender disease, which hits at first young women, characterized by smooth muscle infiltration of the lung alveolar walls, leading to cystic degeneration.While both can occur clinically as isolated conditions, AML and LAM are also common manifestations of tuberous sclerosis complex (TSC), an autosomal dominant disorder characterized by hamartomas involving the central nervous system, skin, liver, heart, and eyes.Individuals diagnosed with TSC develop AMLs by adulthood in 70-90% of cases, whereas LAM can occur in up to 30-40% of affected women.TSC arises from inactivating mutations of either TSC1 (chromosome locus 9q34.3) or TSC2 (16p13.3)genes that encode for hamartin and tuberin, respectively.These proteins regulate cell proliferation and differentiation, and are involved in the mTOR (mammalian target of rapamycin) signaling pathway.Mutations in TSC2 often result in more severe clinical profiles, including higher frequency and severity of renal angiomyolipomas.No pharmacological treatment for AMLs is available and the most common approach is still the surgical ablation in the case of symptomatic disease or for lesions greater than 4 cm.Although the molecular events responsible for AML development are not fully understood, mTOR inhibitor therapy with sirolimus and everolimus may delay the growth and progression of AML in patients with TSC.Trials with sirolimus suggest its efficacy in slowing the evolution of the pulmonary disease.In cases of severe functional respiratory or rapid evolution of the disease, the treatment of election is the pulmonary transplantation.TSC-associated and sporadic AMLs and LAM are more common in female patients.Thus, some Authors have suggested a key role for the estrogen in their development.Nevertheless, it has not been fully clarified yet whether and how hormonal modulation is involved in the different occurrence in male and female patients.The smooth muscle cells of patients affected by both AML and LAM are characterized by structural cytologic analogy and the same somatic mutations; furthermore, AML cells have been detected in donor lungs of patients who had lung transplantation.These observations support the hypothesis that LAM might occur because of the migration of cells from other sites, such as the kidney, lymphatic system, or uterus.Therefore a common cell progenitor originating in the kidney and a metastatic behavior have been suggested.Despite several publications describing AML and LAM, a very few is known about their triggering agents and an eventual correlation between the two pathologies.To date, only a small number of hypotheses have been formulated regarding a link between them, but no proof exists either for or against.In our opinion, the demonstration of a direct link between AML and LAM might be of paramount importance in foreseeing and preventing their evolution, especially in fertileage women.It must be considered that AML and LAM have, at now, a very dramatic evolution and no definitive cure has been established yet.The overall objectives of this study are: 1) to ascertain the migratory proprieties of AML cells, 2) to identify common characteristics that might bind AML and LAM, and 3) to define innovative potential pharmacological approaches able to interfere with proliferation and migration of AML cells. Material and Methods:The study has been performed on two different models: 1) ex vivo experiments on cells isolated from AML, and 2) in vitro experiments on three stabilized AML cell lines.Human primary AMLs cells were isolated from two spontaneous angiomyolipomas, surgically excised from a male (AML3) and a female (AML4) patient, which had neither clinical signs and symptoms nor a family history of tuberous sclerosis.On the other hand, two of the stabilized cell lines were TSC mutated: 4004 male cells carry a mutation in the exon 33 of TSC2 gene (4083-4087 del AGTCG) and 621-101 female cells have biallelic mutations in the exon 16 of TSC2 gene (G1832A).The third cell line (621-103) derives from the 621-101 cell line by restoration of the TSC2 gene.We tested, in vitro, different concentrations and exposure times of drugs employed for the treatment of LAM and AML patients (sirolimus and everolimus) as well as of alternative selected drugs (simvastatin, zoledronic acid, estradiol, and tamoxifen) to evaluate whether they can modulate AML cells proliferation.By means of 2D and 3D migration assays, we assessed if AML cells can migrate and if hormonal stimuli and drugs can modulate this property.Moreover, we evaluated the production of metalloproteases principally involved in malignant phenotype acquisition (MMP-2 and MMP-9) by zymography.Finally, by quantitative RT-PCR, we studied the expression of some genes crucial for the progression of these diseases.Results: In the first part of the study, we isolated and grew cells from primary human spontaneous angiomyolipomas derived from male and female patients.To better understand which type of cells we isolated from fresh masses, we characterized the cellular composition of our cultures by means of immunofluorescence staining against HMB45, Melan-A, S-100, α-Smooth-Muscle Actin, keratin 8/18 and vimentin.The different cellular positivity to the antibodies confirmed the heterogeneous nature of both AMLs.Subsequently, we examined the expression of estrogen receptor genes; the analysis demonstrated that both primary cell cultures express significantly level of mRNA for GPR30 and ERα, but not for ERβ.Moreover, no significant differences in ER gene expressions have been detected between the male and female AMLs.We evaluated if the treatments with 17-β-estradiol, tamoxifen or the combination of both modulated the proliferation and migration of cells.Concentrations comprised between 0.1 and 100 nM of 17-βestradiol or between 0.2 and 20 µM of tamoxifen did not modify cell proliferation.Through the analyses of 2D and 3D migration assays, we observed a different cell behavior.Treatment with estradiol (1 nM) for 2 hours induced a significant increase in 2D motility for both primary cell cultures; in 3D migration assay, only the female cells significantly responded to estrogen after 4 hours.Tamoxifen (2 µM) had no influence on cell motility, but it was able to erase the effects of estradiol.Moreover, we performed a western blot analysis of Erk1/2 phosphorylation, demonstrating that estradiol incubation activates Erk1/2 pathways.Finally, we evaluated if the migration of our cells was modulated by SDF-1α, a chemokine associated with invasion and homing to specific organs.Both cells expressed, in basal condition, similar levels of mRNA for CXCR4, the receptor for SDF-1α.The addition of SDF-1α (100 ng/mL) to the culture medium stimulated the migration of both primary cells already after 4 hours of incubation; the stimulation was coherently abolished by the SDF-1α -receptor antagonist plerixafor (100 nM).At last, we analyzed by zymography the activities of MMP2 and MMP9 on the supernatant collected after 3D migration assay; in both cells treatment with SDF-1α significantly increased MMP-9 activity in both primary cultures.Considering the limited number of primary AML cells available, we strengthened our results by studying the stabilized AML cell lines.In these cells, we evaluated the expression level of specific genes involved in proliferation and migration in either basal condition or under specific drugs treatment.In basal condition, we observed significant expression level of antiapoptotic factors, enzymes involved in the metastatic process, and elements involved in dedifferentiation processes in all cell lines.At the same concentrations and time tested for primary cells, the treatment with 17-β-estradiol did not induce any significant modification on cell proliferation.Unexpectedly, the proliferation of cell lines was inhibited by 10 µM tamoxifen already after 24 hours.In three-dimensional migration assay, incubation with estradiol, tamoxifen or both did not modify the migration ratio for male 4004 cells.On the other hand, 1 nM 17-β-estradiol significantly increased the rate of female 621-101 and 621-103 cells migration; 2 µM tamoxifen increased the migration of these cells also, even if less than compared with 17-β-estradiol (P<0.05).The different behavior of male and female cells was also confirmed, after 4 hours of incubation with the same concentration of 17-β-estradiol, by the increments in the expression level of several genes (such as MMPs, cMET, VEGF, FN1, and IGFR1) involved in motility and cellular adhesion.Treatment with everolimus (1-100 nM), zoledronic acid, and simvastatin (1-100 µM) had a direct toxic effect on AML cells, though at different concentrations and incubation time.Moreover, we tested these drugs in association or alone in a 3D migration assay.For all cell lines, the combination of everolimus and zoledronic acid strongly inhibited the migration at low concentration.We also observed a decrease of migratory capacity induced by 10 µM simvastatin, that inhibits cell migration already after 4 hours (P<0.05). Conclusion:Our results suggest that significant differences between the analyzed AMLs are present for what concerns the response to the tested molecules.Both primary and stabilized cells have basic migratory properties.The migration of primary cells is likely modulated by agonists such as SDF-1α and 17-β-estradiol, as confirmed by the quenching effect of their blockers.Primary cells increase their migration under estrogen influences independently from their gender.This confirms the hypothesis of a potential involvement in propagation and colonization to lung or other organs.In stabilized cells, the female ones are more responsive to estrogenic stimulation in terms of three-dimens
Institution: University of Turin
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7217669124
Cites: 140
Cited by:
Related to: 10